Molecular Markers of Antimalarial Drug Resistance in Plasmodium falciparum From Kumasi, Ghana, 2023
Tropical Medicine & International Health · 2026-01 · 31 (1) · 43-48
DOI: 10.1111/tmi.70048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tropical Medicine & International Health, online erschienen am 15.10.2025. Verfasst von Albert Dennis Kegya und 10 weiteren Autor:innen. Beteiligte Einrichtung: Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana. Hauptthemen laut MEDLINE: Plasmodium falciparum, Antimalarials, Drug Resistance, Malaria, Falciparum. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federal Ministry for Economic Cooperation and Development, Else Kröner-Fresenius-Stiftung, Bundesministerium für Wirtschaftliche Zusammenarbeit und Entwicklung.
Abstract (Originalsprache)
Objectives
Artemisinin partial resistance has emerged in East Africa and is feared to spread across the continent, potentially compromising artemisinin‐based combination treatment. Molecular markers can serve as early warning signals for the development of specific drug resistance. We aimed at updating information on relevant resistance markers among Plasmodium falciparum from Kumasi, Ghana, collected in 2023.
Methods
P. falciparum isolates were obtained from 200 patients with falciparum malaria. Mutations in pfk13 (propeller domain), pfcoronin (P76S), pfmdr1 (N86Y, Y184F, Y1246D) and pfaat1 (S258L) were genotyped. A subset of patients was microscopically examined for the presence of asexual malaria parasites on day‐3 of treatment with artemether‐lumefantrine.
Results
2.2% of isolates exhibited non‐synonymous pfk13 mutations including the candidate artemisinin partial resistance marker P527H in addition to S522C, C532S and I590V. Pfcoronin P76S, previously associated with artemether‐lumefantrine failure in malaria imported from Africa, was present in 29.7% and associated with a lower parasite density. The predominance of the pfmdr1 pattern N86‐184F‐D1246 (NFD) suggested impaired sensitivity to lumefantrine. Pfaat1 S258L was common at 64.7%. The resistance markers were not associated with each other, and they were not linked with day‐3 parasite positivity.
Conclusions
While the efficacy of artemisinin‐based combination treatment in Ghana is still high, isolated critical pfk13 polymorphisms were identified as well as a considerable prevalence of a potentially relevant pfcoronin marker, against a background of pfmdr1 signals for impaired lumefantrine sensitivity. Continuous molecular monitoring is necessary to detect threats to artemisinin‐based combination treatment efficacy at an early stage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana.
- University Hospital, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
- Center for Tropical Medicine, Bernhard-Nocht-Institute for Tropical Medicine & I. Dep. of Medicine University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
- Department of Internal Medicine, University Hospital and University of Zurich, Zurich, Switzerland.
- German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.
- University Teaching Hospital of Butare, University of Rwanda, Butare, Rwanda.
ORCID-Profile: Albert Dennis Kegya, Kwame Ayisi Boateng, Richard Odame Phillips, Melina Heinemann, Michael Ramharter, Frank P Mockenhaupt, Welmoed van Loon
Förderung
- Federal Ministry for Economic Cooperation and Development
- Else Kröner-Fresenius-Stiftung
- Bundesministerium für Wirtschaftliche Zusammenarbeit und Entwicklung
Zitieren
APA
Kegya, A. D., Oppong, E., Darko, E., Boateng, K. A., Phillips, R. O., Heinemann, M., Ramharter, M., Igiraneza, C., Ndoli, J. M., Mockenhaupt, F. P., & van Loon, W. (2026). Molecular Markers of Antimalarial Drug Resistance in Plasmodium falciparum From Kumasi, Ghana, 2023. Tropical Medicine & International Health, 31(1), 43-48. https://doi.org/10.1111/tmi.70048
Vancouver
Kegya AD, Oppong E, Darko E, Boateng KA, Phillips RO, Heinemann M, et al. Molecular Markers of Antimalarial Drug Resistance in Plasmodium falciparum From Kumasi, Ghana, 2023. Tropical Medicine & International Health. 2026;31(1):43-48. doi:10.1111/tmi.70048
BibTeX
@article{Kegya2026,
author = {Kegya, Albert Dennis and Oppong, Elizabeth and Darko, Eric and Boateng, Kwame Ayisi and Phillips, Richard Odame and Heinemann, Melina and Ramharter, Michael and Igiraneza, Clement and Ndoli, Jules Minega and Mockenhaupt, Frank P and van Loon, Welmoed},
title = {Molecular Markers of Antimalarial Drug Resistance in Plasmodium falciparum From Kumasi, Ghana, 2023},
journal = {Tropical Medicine & International Health},
year = {2026},
volume = {31},
number = {1},
pages = {43--48},
doi = {10.1111/tmi.70048}
}
EUVIMED